These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26122850)

  • 1. Complete remission after rituximab therapy in an HIV-positive patient with pemphigus vulgaris.
    Polansky M; Patel N; Feldman R
    Br J Dermatol; 2015 Dec; 173(6):1557-9. PubMed ID: 26122850
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical resolution of pemphigus vulgaris on rituximab.
    Cusick E; Silverstein D
    Dermatol Online J; 2017 Sep; 23(9):. PubMed ID: 29469734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rituximab induced remission of pemphigus vulgaris: 2 cases].
    Borel C; Launay F; Garrouste C; Astudillo L; Bazex J; Arlet P; Paul C; Viraben R; Sailler L
    Rev Med Interne; 2007 Apr; 28(4):266-8. PubMed ID: 17188405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Remissions in Recalcitrant Pemphigus Vulgaris.
    Ahmed AR; Kaveri S; Spigelman Z
    N Engl J Med; 2015 Dec; 373(27):2693-4. PubMed ID: 26716930
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
    Morrison LH
    J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-desmoglein antibody-negative paraneoplastic pemphigus successfully treated with rituximab.
    Kanwar AJ; Vinay K; Varma S; Koga H; Ishii N; Hashimoto T
    Int J Dermatol; 2015; 54(5):576-9. PubMed ID: 24738571
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term remission with rituximab therapy in a five-year-old patient with pemphigus vulgaris.
    Erdoğan B; Meral EN; Topkarci Z; Hatipoğlu N; Kavak A
    J Dtsch Dermatol Ges; 2024 Feb; 22(2):292-294. PubMed ID: 38009460
    [No Abstract]   [Full Text] [Related]  

  • 8. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
    Greenblatt DT; Benton EC; Groves RW; Setterfield JF
    Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab therapy in pemphigus foliaceus: report of 12 cases and review of recent literature.
    de Sena Nogueira Maehara L; Huizinga J; Jonkman MF
    Br J Dermatol; 2015; 172(5):1420-3. PubMed ID: 25496559
    [No Abstract]   [Full Text] [Related]  

  • 10. Resolution of a case of pediatric pemphigus vulgaris treated with rituximab.
    Didona D; Paolino G; Donati M; Caposeina D; Calvieri S; Didona B
    Acta Dermatovenerol Croat; 2014; 22(4):288-90. PubMed ID: 25580789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-endemic erythrodermic pemphigus foliaceus: a case with delayed diagnosis and response to rituximab.
    Patsatsi A; Kyriakou A; Douma S; Kokolios M; Meltzanidou P; Lambropoulos A; Sotiriadis D
    J Dtsch Dermatol Ges; 2019 May; 17(5):537-539. PubMed ID: 30994241
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.
    Uzun S; Bilgiç Temel A; Akman Karakaş A; Ergün E; Özkesici B; Eskiocak AH; Erat A; Uğurlu N; Nazlım B; Koç S; Bozkurt S; Dicle Ö; Alpsoy E; Yılmaz E
    Int J Dermatol; 2016 Dec; 55(12):1362-1368. PubMed ID: 27653507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of severe refractory pemphigus vulgaris with rituximab].
    Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
    Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting remission of pemphigus vulgaris treated with rituximab.
    Esposito M; Capriotti E; Giunta A; Bianchi L; Chimenti S
    Acta Derm Venereol; 2006; 86(1):87-9. PubMed ID: 16586007
    [No Abstract]   [Full Text] [Related]  

  • 15. Rituximab Therapy for Childhood Pemphigus Vulgaris.
    Kincaid L; Weinstein M
    Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal Outcomes after Rituximab Therapy for Pemphigus Vulgaris.
    Tovanabutra N; Bax CE; Feng R; Kushner CJ; Payne AS
    J Invest Dermatol; 2022 Apr; 142(4):1058-1064.e7. PubMed ID: 34710389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the Effects of Rituximab Monotherapy on Different Subsets of Circulating T-Regulatory Cells and Clinical Disease Severity in Severe Pemphigus Vulgaris.
    Bhattacharjee R; De D; Handa S; Minz RW; Saikia B; Joshi N
    Dermatology; 2016; 232(5):572-577. PubMed ID: 27576321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.
    Ahmed AR; Spigelman Z; Cavacini LA; Posner MR
    N Engl J Med; 2006 Oct; 355(17):1772-9. PubMed ID: 17065638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab administration in a patient with pemphigus vulgaris following reactivation of occult hepatitis B virus infection.
    Tavakolpour S; Soori T; Noormohammadpour P; Balighi K; Mahmoudi H; Daneshpazhooh M
    Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab and intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the treatment of pemphigus: a single center case series of 63 patients.
    Brown AE; Motaparthi K; Hsu S
    Dermatol Online J; 2018 Jan; 23(12):. PubMed ID: 29447653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.